Project Number 5P50AG005131-34 Agency/Funding Organization NIA Funding Year 2017 View Full Project Details for Probing SORL1 Risk Factors with Human Induced Pluripotent Stem Cell Technology Research Categorization Primary Disease / Condition Multiple Dementias CADRO Category C. Translational Research and Clinical Interventions 1. Research Resources and Enabling Technologies to Accelerate Therapy Development a. Enabling Technologies Category F. Research Resources 1. Alzheimer's Disease Centers Researcher and Organization Principal Investigator GOLDSTEIN, LAWRENCE S Principal Investigator First Name LAWRENCE Principal Investigator Last Name GOLDSTEIN Awardee Organization UNIVERSITY OF CALIFORNIA SAN DIEGO Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-AG-13-019: Alzheimer's Disease Research Centers (P50) FY Overall Cost $165,609 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official SILVERBERG, NINA B Related Resources Repository [NIAGADS] Transethnic GWAS Summary Statistics - Jun et al. (2017) [NIAGADS] ADC1- Alzheimer Disease Center Dataset 1 [NIAGADS] ADC2- Alzheimer Disease Center Dataset 2 [NIAGADS] ADC3- Alzheimer Disease Center Dataset 3 [NIAGADS] ADGC African American Summary Statistics- Reitz et al. (2013) [NIAGADS] ADGC Neuropath Summary Stats and Phenotypes- Beecham et al. (2014) [NIAGADS] ADGC Summary Statistics- Naj et al. (2011) University of San Diego Alzheimer's Disease Research Center National Alzheimer's Coordinating Center (NACC) [AlzPED] An Anti-β-Amyloid Vaccine for Treating Cognitive Deficits in a Mouse Model of Down Syndrome. Pagination Page 1 Next page ››
